Stemtech

Stemtech is a company listed under the stock ticker STEK (US).

View the org chart displaying its 12 main executives

Most searched biographies at Stemtech

• Charles Arnold, Chief Executive Officer and Chairman of the Board
• Darryl Green, Director
• John Thatch, Director

Create your alert
to follow the executive moves at Stemtech.

Stemtech has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Lucia Aleotti - Director at Menarini Group

Learn more about the Pharmaceuticals industry >

Press releases by Stemtech

• Stemtech Corporation
• Stemtech Holds Global Leaders Convention

Social media about Stemtech

• Stemtech on Wikipedia, Google News & Yahoo Finance
• Stemtech on LinkedIn, Twitter & YouTube

Contact by email its executives including Charles Arnold

Call Stemtech at +1 954...

View the org chart

Register to receive your alert

Report an error